163 related articles for article (PubMed ID: 33880581)
21. Long non‑coding RNA SNHG12 regulates cell proliferation, invasion and migration in endometrial cancer by targeting miR‑4429.
Cai P; Wu M; Zhang B; Wu S; Wei H; Wei L
Mol Med Rep; 2020 Oct; 22(4):2842-2850. PubMed ID: 32945395
[TBL] [Abstract][Full Text] [Related]
22. Protocadherin-8 promotes invasion and metastasis via laminin subunit γ2 in gastric cancer.
Lin Y; Ge X; Zhang X; Wu Z; Liu K; Lin F; Dai C; Guo W; Li J
Cancer Sci; 2018 Mar; 109(3):732-740. PubMed ID: 29325230
[TBL] [Abstract][Full Text] [Related]
23. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
24. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
25. Laminin‑332 mediates proliferation, apoptosis, invasion, migration and epithelial‑to‑mesenchymal transition in pancreatic ductal adenocarcinoma.
Huang C; Chen J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179081
[TBL] [Abstract][Full Text] [Related]
26. LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer.
Cave DD; Buonaiuto S; Sainz B; Fantuz M; Mangini M; Carrer A; Di Domenico A; Iavazzo TT; Andolfi G; Cortina C; Sevillano M; Heeschen C; Colonna V; Corona M; Cucciardi A; Di Guida M; Batlle E; De Luca A; Lonardo E
J Exp Clin Cancer Res; 2022 Oct; 41(1):315. PubMed ID: 36289544
[TBL] [Abstract][Full Text] [Related]
27. LAMC2 acts as a novel therapeutic target of cetuximab in laryngeal cancer.
Wang QY; Liu YC; Zhou SH; Chen HH
Neoplasma; 2021 Nov; 68(6):1257-1264. PubMed ID: 34533031
[TBL] [Abstract][Full Text] [Related]
28. miR‑140‑5p inhibits the proliferation of multiple myeloma cells by targeting VEGFA.
Liu M; Liu H; Zhou J; Yu Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200797
[TBL] [Abstract][Full Text] [Related]
29. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.
Liang Y; Chen X; Wu Y; Li J; Zhang S; Wang K; Guan X; Yang K; Bai Y
Cell Death Differ; 2018 Nov; 25(11):1980-1995. PubMed ID: 29511340
[TBL] [Abstract][Full Text] [Related]
30. LAMC2 enhances the metastatic potential of lung adenocarcinoma.
Moon YW; Rao G; Kim JJ; Shim HS; Park KS; An SS; Kim B; Steeg PS; Sarfaraz S; Changwoo Lee L; Voeller D; Choi EY; Luo J; Palmieri D; Chung HC; Kim JH; Wang Y; Giaccone G
Cell Death Differ; 2015 Aug; 22(8):1341-52. PubMed ID: 25591736
[TBL] [Abstract][Full Text] [Related]
31. Dexmedetomidine Regulates Proliferation, Apoptosis, Migration, and Invasion in Ovarian Cancer Cells via MiR-155-HIF-1α Axis.
Zheng L; Jia R; Zhao J
Med Sci Monit; 2019 Dec; 25():10164-10172. PubMed ID: 31887107
[TBL] [Abstract][Full Text] [Related]
32. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.
Zheng J; Zhou Y; Li XJ; Hu JM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483
[TBL] [Abstract][Full Text] [Related]
33. miR-183 modulated cell proliferation and apoptosis in ovarian cancer through the TGF-β/Smad4 signaling pathway.
Zhou J; Zhang C; Zhou B; Jiang D
Int J Mol Med; 2019 Apr; 43(4):1734-1746. PubMed ID: 30720057
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer.
Diao B; Yang P
Pathol Oncol Res; 2021; 27():1609855. PubMed ID: 34512203
[TBL] [Abstract][Full Text] [Related]
35. RUNX2 and LAMC2: promising pancreatic cancer biomarkers identified by an integrative data mining of pancreatic adenocarcinoma tissues.
Jin G; Ruan Q; Shangguan F; Lan L
Aging (Albany NY); 2021 Oct; 13(19):22963-22984. PubMed ID: 34606473
[TBL] [Abstract][Full Text] [Related]
36. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.
Wang K; Jin J; Ma T; Zhai H
Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289
[TBL] [Abstract][Full Text] [Related]
37. Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis.
Xu H; Wang L; Jiang X
Mol Cell Biochem; 2021 Feb; 476(2):1051-1061. PubMed ID: 33170430
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
Sun Z; Gao S; Xuan L; Liu X
J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
[TBL] [Abstract][Full Text] [Related]
39. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
[TBL] [Abstract][Full Text] [Related]
40. Long non‑coding RNA NEAT1 modifies cell proliferation, colony formation, apoptosis, migration and invasion via the miR‑4500/BZW1 axis in ovarian cancer.
Xu H; Sun X; Huang Y; Si Q; Li M
Mol Med Rep; 2020 Oct; 22(4):3347-3357. PubMed ID: 32945505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]